baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Trevena Inc/ US89532E2081 /

2024-04-25 10:00:00 PM	Chg. +0.0280	Volume	Bid11:41:19 PM	Ask11:41:19 PM	High	Low
0.4090USD	+7.35%	114,796 Turnover: 43,297.5779	0.3722Bid Size: 1,200	0.4100Ask Size: 21,400	0.4199	0.3700

GlobeNewswire 04-01 Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

GlobeNewswire 03-27 One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors

GlobeNewswire 2023-12-28 Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise

GlobeNewswire 2023-12-27 Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise

GlobeNewswire 2023-12-04 Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual...

GlobeNewswire 2023-12-04 Trevena Awarded OLINVYK Agreement with Premier, Inc.

GlobeNewswire 2023-11-30 Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn In...

GlobeNewswire 2023-11-14 Trevena Reports Third Quarter 2023 Results and Provides Business Update

GlobeNewswire 2023-11-09 Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire 2023-10-16 Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data from Proof-of-Concept Studies

GlobeNewswire 2023-10-02 Trevena Announces Completion of Initial Analysis of OLINVYK Continuous Respiratory Monitoring Data f...

GlobeNewswire 2023-09-06 Trevena Announces Receipt of $15 Million Non-Dilutive Tranche and Provides General Business Update

GlobeNewswire 2023-09-06 Trevena Announces Preliminary TRV045 Data from Two Proof-of-Concept Studies Evaluating S1PR Mechanis...

GlobeNewswire 2022-02-03 Trevena to Present at the 2022 BIO CEO & Investor Conference

GlobeNewswire 2022-01-27 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nh...

GlobeNewswire 2022-01-03 Trevena to Participate in the Upcoming January Conferences

GlobeNewswire 2021-11-15 Trevena Reports Third Quarter 2021 Results

GlobeNewswire 2021-11-11 Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

GlobeNewswire 2021-11-10 VectivBio Announces Third Quarter 2021 Business Update

GlobeNewswire 2021-11-08 Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021

GlobeNewswire 2021-11-02 70th Miss USA® Competition to Air Live from Tulsa, Oklahoma, on Nov. 29, 2021, on FYI and Hulu

GlobeNewswire 2021-10-13 Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021

GlobeNewswire 2021-09-30 Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients

GlobeNewswire 2021-09-17 Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit

GlobeNewswire 2021-09-09 Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Trevena Inc/ US89532E2081 /

If you wish to receive reply to your feedback, please provide your email address.